New hope for kids with tough cancers: trial tests aggressive drug combo
NCT ID NCT07444918
Summary
This study is testing whether a combination of four cancer drugs can help control aggressive solid tumors in children and teenagers when standard treatments have failed. It will involve about 33 young patients (ages 3-18) at a single hospital in China. The main goal is to see if the tumors shrink and to carefully monitor side effects, with treatment plans adjusted based on how each child responds.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY PEDIATRIC MALIGNANT SOLID TUMORS (INCLUDING NEUROBLASTOMA, RHABDOMYOSARCOMA, EWING SARCOMA, OSTEOSARCOMA) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.